{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,30]],"date-time":"2026-03-30T13:21:46Z","timestamp":1774876906391,"version":"3.50.1"},"reference-count":35,"publisher":"Spandidos Publications","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.3892\/ijo.2014.2769","type":"journal-article","created":{"date-parts":[[2014,11,21]],"date-time":"2014-11-21T08:51:01Z","timestamp":1416559861000},"page":"555-562","source":"Crossref","is-referenced-by-count":47,"title":["Wedelolactone inhibits breast cancer-induced osteoclastogenesis by decreasing Akt\/mTOR signaling"],"prefix":"10.3892","volume":"46","author":[{"given":"CHIA-JUNG","family":"HSIEH","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"PO-LIN","family":"KUO","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"MING-FENG","family":"HOU","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JEN-YU","family":"HUNG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"FANG-RONG","family":"CHANG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YING-CHAN","family":"HSU","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YA-FANG","family":"HUANG","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"EING-MEI","family":"TSAI","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"YA-LING","family":"HSU","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"2249","published-online":{"date-parts":[[2014,11,21]]},"reference":[{"key":"key20180107184043_b1-ijo-46-02-0555","doi-asserted-by":"crossref","first-page":"3","DOI":"10.4161\/cbt.7.1.5163","article-title":"Biology of breast cancer bone metastasis","volume":"7","author":"Akhtari","year":"2008","journal-title":"Cancer Biol Ther"},{"key":"key20180107184043_b2-ijo-46-02-0555","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.breast.2014.05.023","article-title":"Bone health in breast cancer patients: a comprehensive statement by CECOG\/SAKK intergroup","volume":"23","author":"Rordorf","year":"2014","journal-title":"Breast"},{"key":"key20180107184043_b3-ijo-46-02-0555","first-page":"21","article-title":"Metastatic cancer in solid tumors and clinical outcome: skeletal-related events","volume":"23","author":"Rove","year":"2009","journal-title":"Oncology"},{"key":"key20180107184043_b4-ijo-46-02-0555","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/nrc3055","article-title":"Cancer to bone: a fatal attraction","volume":"11","author":"Weilbaecher","year":"2011","journal-title":"Nat Rev Cancer"},{"key":"key20180107184043_b5-ijo-46-02-0555","doi-asserted-by":"crossref","first-page":"151","DOI":"10.4103\/0975-5950.127643","article-title":"Bisphophonates related osteonecrosis of the jaw","volume":"4","author":"Gupta","year":"2013","journal-title":"Natl J Maxillofac Surg"},{"key":"key20180107184043_b6-ijo-46-02-0555","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1016\/j.drudis.2014.04.004","article-title":"Therapeutic strategies for treating osteolytic bone metastases","volume":"19","author":"Verron","year":"2014","journal-title":"Drug Discov Today"},{"key":"key20180107184043_b7-ijo-46-02-0555","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1056\/NEJMra030831","article-title":"Mechanisms of bone metastasis","volume":"350","author":"Roodman","year":"2004","journal-title":"N Engl J Med"},{"key":"key20180107184043_b8-ijo-46-02-0555","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/nrc867","article-title":"Metastasis to bone: causes, consequences and therapeutic opportunities","volume":"2","author":"Mundy","year":"2002","journal-title":"Nat Rev Cancer"},{"key":"key20180107184043_b9-ijo-46-02-0555","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1126\/science.289.5484.1508","article-title":"Therapeutic approaches to bone diseases","volume":"289","author":"Rodan","year":"2000","journal-title":"Science"},{"key":"key20180107184043_b10-ijo-46-02-0555","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1210\/edrv.20.3.0367","article-title":"Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families","volume":"20","author":"Suda","year":"1999","journal-title":"Endocr Rev"},{"key":"key20180107184043_b11-ijo-46-02-0555","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0006-291X(03)00695-8","article-title":"Signal transduction by receptor activator of nuclear factor kappa B in osteoclasts","volume":"305","author":"Lee","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"key20180107184043_b12-ijo-46-02-0555","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1186\/bcr2781","article-title":"Breast cancer metastasis to the bone: mechanisms of bone loss","volume":"12","author":"Chen","year":"2010","journal-title":"Breast Cancer Res"},{"key":"key20180107184043_b13-ijo-46-02-0555","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1080\/02841860600635870","article-title":"Abnormal bone remodeling process is due to an imbalance in the receptor activator of nuclear factor-kappaB ligand (RANKL)\/osteoprotegerin (OPG) axis in patients with solid tumors metastatic to the skeleton","volume":"46","author":"Mountzios","year":"2007","journal-title":"Acta Oncol"},{"key":"key20180107184043_b14-ijo-46-02-0555","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1097\/JTO.0b013e318229421f","article-title":"OPG\/RANKL\/RANK pathway as a therapeutic target in cancer","volume":"6","author":"McGrath","year":"2011","journal-title":"J Thorac Oncol"},{"key":"key20180107184043_b15-ijo-46-02-0555","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jnci.2012.06.002","article-title":"Bone metastasis in breast cancer: the story of RANK-ligand","volume":"24","author":"Azim","year":"2012","journal-title":"J Egypt Nat Cancer Inst"},{"key":"key20180107184043_b16-ijo-46-02-0555","doi-asserted-by":"crossref","first-page":"689","DOI":"10.4103\/0250-474X.45421","article-title":"Simultaneous estimation of andrographolide and wedelolactone in herbal formulations","volume":"70","author":"Patel","year":"2008","journal-title":"Indian J Pharm Sci"},{"key":"key20180107184043_b17-ijo-46-02-0555","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s00403-008-0860-3","article-title":"Hair growth promoting activity of Eclipta alba in male albino rats","volume":"300","author":"Roy","year":"2008","journal-title":"Arch Dermatol Res"},{"key":"key20180107184043_b18-ijo-46-02-0555","first-page":"435","article-title":"In vivo hepatoprotective activity of active fraction from ethanolic extract of Eclipta alba leaves","volume":"45","author":"Singh","year":"2001","journal-title":"Indian J Physiol Pharmacol"},{"key":"key20180107184043_b19-ijo-46-02-0555","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1055\/s-2007-969188","article-title":"Coumestans as the main active principles of the liver drugs Eclipta alba and Wedelia calendulacea","author":"Wagner","year":"1986","journal-title":"Planta Med"},{"key":"key20180107184043_b20-ijo-46-02-0555","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1093\/carcin\/bgm137","article-title":"Compounds from Wedelia chinensis synergistically suppress androgen activity and growth in prostate cancer cells","volume":"28","author":"Lin","year":"2007","journal-title":"Carcinogenesis"},{"key":"key20180107184043_b21-ijo-46-02-0555","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1002\/ptr.2252","article-title":"HIV-1 protease and HIV-1 integrase inhibitory substances from Eclipta prostrata","volume":"21","author":"Tewtrakul","year":"2007","journal-title":"Phytother Res"},{"key":"key20180107184043_b22-ijo-46-02-0555","doi-asserted-by":"crossref","first-page":"5435","DOI":"10.1158\/1078-0432.CCR-09-0298","article-title":"Herbal extract of Wedelia chinensis attenuates androgen receptor activity and orthotopic growth of prostate cancer in nude mice","volume":"15","author":"Tsai","year":"2009","journal-title":"Clin Cancer Res"},{"key":"key20180107184043_b23-ijo-46-02-0555","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1227\/01.neu.0000325874.82999.75","article-title":"Inhibition of NFkappaB reduces cellular viability in GH3 pituitary adenoma cells","volume":"62","author":"Vender","year":"2008","journal-title":"Neurosurgery"},{"key":"key20180107184043_b24-ijo-46-02-0555","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1158\/1535-7163.MCT-09-0133","article-title":"Pharmacologic inhibitors of IkappaB kinase suppress growth and migration of mammary carcinosarcoma cells in vitro and prevent osteolytic bone metastasis in vivo","volume":"8","author":"Idris","year":"2009","journal-title":"Mol Cancer Ther"},{"key":"key20180107184043_b25-ijo-46-02-0555","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.3892\/ijo.2012.1664","article-title":"Wedelolactone, a medicinal plant-derived coumestan, induces caspase-dependent apoptosis in prostate cancer cells via downregulation of PKC\u025b without inhibiting Akt","volume":"41","author":"Sarveswaran","year":"2012","journal-title":"Int J Oncol"},{"key":"key20180107184043_b26-ijo-46-02-0555","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.bone.2010.07.015","article-title":"Advances in the biology of bone metastasis: how the skeleton affects tumor behavior","volume":"48","author":"Sterling","year":"2011","journal-title":"Bone"},{"key":"key20180107184043_b27-ijo-46-02-0555","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1007\/s10585-011-9398-4","article-title":"Erlotinib inhibits osteolytic bone invasion of human non-small-cell lung cancer cell line NCI-H292","volume":"28","author":"Furugaki","year":"2011","journal-title":"Clin Exp Metastasis"},{"key":"key20180107184043_b28-ijo-46-02-0555","doi-asserted-by":"crossref","first-page":"37335","DOI":"10.1074\/jbc.M111.256156","article-title":"Lung tumor-associated osteoblast-derived bone morphogenetic protein-2 increased epithelial-to-mesenchymal transition of cancer by Runx2\/Snail signaling pathway","volume":"286","author":"Hsu","year":"2011","journal-title":"J Biol Chem"},{"key":"key20180107184043_b29-ijo-46-02-0555","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1749-6632.2009.05303.x","article-title":"New immune connections in osteoclast formation","volume":"192","author":"Takayanagi","year":"2010","journal-title":"Ann NY Acad Sci"},{"key":"key20180107184043_b30-ijo-46-02-0555","doi-asserted-by":"crossref","first-page":"178","DOI":"10.5312\/wjo.v4.i4.178","article-title":"Role of RANKL\/RANK in primary and secondary breast cancer","volume":"4","author":"Yoneda","year":"2013","journal-title":"World J Orthop"},{"key":"key20180107184043_b31-ijo-46-02-0555","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.ccr.2006.08.022","article-title":"Akt deficiency impairs normal cell proliferation and suppresses oncogenesis in a p53-independent and mTORC1-dependent manner","volume":"10","author":"Skeen","year":"2006","journal-title":"Cancer Cell"},{"key":"key20180107184043_b32-ijo-46-02-0555","doi-asserted-by":"crossref","first-page":"163","DOI":"10.4049\/jimmunol.1101254","article-title":"Akt induces osteoclast differentiation through regulating the GSK3\u03b2\/NFATc1 signaling cascade","volume":"188","author":"Moon","year":"2012","journal-title":"J Immunol"},{"key":"key20180107184043_b33-ijo-46-02-0555","doi-asserted-by":"crossref","first-page":"30399","DOI":"10.1074\/jbc.M113.469973","article-title":"Critical role of AKT protein in myeloma-induced osteoclast formation and osteolysis","volume":"288","author":"Cao","year":"2013","journal-title":"J Biol Chem"},{"key":"key20180107184043_b34-ijo-46-02-0555","doi-asserted-by":"crossref","first-page":"3583","DOI":"10.1074\/jbc.M410480200","article-title":"Akt1\/Akt2 and mammalian target of rapamycin\/Bim play critical roles in osteoclast differentiation and survival, respectively, whereas Akt is dispensable for cell survival in isolated osteoclast precursors","volume":"280","author":"Sugatani","year":"2005","journal-title":"J Biol Chem"},{"key":"key20180107184043_b35-ijo-46-02-0555","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1471-2431-9-3","article-title":"Bone growth during rapamycin therapy in young rats","volume":"9","author":"Sanchez","year":"2009","journal-title":"BMC Pediatr"}],"container-title":["International Journal of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/spandidos-publications.com\/10.3892\/ijo.2014.2769\/download","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,1,7]],"date-time":"2018-01-07T18:44:27Z","timestamp":1515350667000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.spandidos-publications.com\/10.3892\/ijo.2014.2769"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11,21]]},"references-count":35,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2014,11,21]]},"published-print":{"date-parts":[[2015,2]]}},"alternative-id":["10.3892\/ijo.2014.2769"],"URL":"https:\/\/doi.org\/10.3892\/ijo.2014.2769","relation":{},"ISSN":["1019-6439","1791-2423"],"issn-type":[{"value":"1019-6439","type":"print"},{"value":"1791-2423","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11,21]]}}}